News

  • CTS Inc. up and running

    CTS is a new business focused on delivering cancer theranostic products - combining imaging with therapy. The lead platform is a gene-based technology based on cancer cell-specific gene promoters, licenced from Johns Hopkins University, VCU and Columbia University.

    Read article